Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Quantum-Si incorporated

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

BRANFORD, CONN., AUG. 18, 2026 (GLOBE NEWSWIRE) -- QUANTUM-SI INCORPORATED (NASDAQ: QSI) ("QUANTUM-SI," "QSI" OR THE "COMPANY"), A PROTEOMICS TECHNOLOGY COMPANY REDEFINING PROTEIN ANALYSIS THROUGH SINGLE-MOLECULE PROTEIN SEQUENCING, TODAY ANNOUNCED THAT IT WILL BE PARTICIPATING IN THE H.C.

QUANTUM-SI TO PARTICIPATE IN THE H.C. WAINWRIGHT 28TH ANNUAL GLOBAL INVESTMENT CONFERENCE

COMPANY UPDATES ANTICIPATED COMMERCIAL LAUNCH OF PROTEUS TO Q2 2027, COST-REDUCTION ACTIONS EXPECTED TO EXTEND CASH RUNWAY INTO Q4 2028 AND HIGHLIGHTS ESTIMATED NEW MARKET OPPORTUNITIES FOR PROTEIN SEQUENCING BRANFORD, CONN., AUG. 13, 2026 (GLOBE NEWSWIRE) -- QUANTUM-SI INCORPORATED (NASDAQ: QSI) (QUANTUM-SI, QSI OR THE COMPANY), A PROTEOMICS TECHNOLOGY COMPANY REDEFINING PROTEIN ANALYSIS THROUGH SINGLE-MOLECULE PROTEIN SEQUENCING, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE30, 2026.

QUANTUM-SI REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES PROTEUS DEVELOPMENT UPDATE

BRANFORD, CONN., JULY 27, 2026 (GLOBE NEWSWIRE) -- QUANTUM-SI INCORPORATED (NASDAQ: QSI) (QUANTUM-SI, QSI OR THE COMPANY), A PROTEOMICS TECHNOLOGY COMPANY REDEFINING PROTEIN ANALYSIS THROUGH SINGLE-MOLECULE DETECTION,TODAY ANNOUNCED THAT IT WILL REPORT FINANCIAL RESULTS FOR THE SECOND QUARTER 2026 ON THURSDAY, AUGUST 13, 2026.

QUANTUM-SI TO REPORT SECOND QUARTER 2026 FINANCIAL RESULTS ON AUGUST 13, 2026

BRANFORD, CONN.--(BUSINESS WIRE)--QUANTUM-SI ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4).

QUANTUM-SI ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

BRANFORD, CONN.--(BUSINESS WIRE)--QUANTUM-SI AND CELL SIGNALING TECHNOLOGY PARTNER TO ADVANCE POST-TRANSLATIONAL MODIFICATION ANALYSIS ON PROTEUS.

QUANTUM-SI AND CELL SIGNALING TECHNOLOGY PARTNER TO ADVANCE POST-TRANSLATIONAL MODIFICATION ANALYSIS ON PROTEUS

BRANFORD, CONN.--(BUSINESS WIRE)--QUANTUM-SI ANNOUNCES THE EXPANSION OF THE PROTEUS ROADSHOW.

QUANTUM-SI ANNOUNCES THE EXPANSION OF THE PROTEUS ROADSHOW

LONDON--(BUSINESS WIRE)-- #5G--ADTRAN AND EUNETWORKS TODAY ANNOUNCED THEIR COLLABORATION ON THE LAUNCH OF A NEW QUANTUM-SAFE PRIVATE CONNECTIVITY SERVICE, QUANTUM SHIELD. EUNETWORKS HAS DEVELOPED QUANTUM SHIELD USING ADTRAN'S OPTICAL TRANSPORT TECHNOLOGY TO AUGMENT ITS BROADER ARCHITECTURE, WHICH IS DESIGNED TO DELIVER SECURE, SCALABLE DATA CENTER CONNECTIVITY ACROSS EUNETWORKS' PAN-EUROPEAN NETWORK. THE NEW OFFERING IS BUILT FOR ENTERPRISES WITH STRINGENT SECURITY, PERFORMANCE AND CUSTOMER-CONTROLLE.

EUNETWORKS LAUNCHES NEW QUANTUM-SAFE PRIVATE CONNECTIVITY SERVICE POWERED BY ADTRAN'S ENCRYPTED OPTICAL TRANSPORT TECHNOLOGY

BRANFORD, CONN.--(BUSINESS WIRE)--QUANTUM-SI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS PROTEUS DEVELOPMENT MILESTONES.

QUANTUM-SI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS PROTEUS DEVELOPMENT MILESTONES

BRANFORD, CONN.--(BUSINESS WIRE)--QUANTUM-SI TO PARTICIPATE IN THE H.C. WAINWRIGHT 4TH ANNUAL BIOCONNECT INVESTOR CONFERENCE.

QUANTUM-SI TO PARTICIPATE IN THE H.C. WAINWRIGHT 4TH ANNUAL BIOCONNECT INVESTOR CONFERENCE AT NASDAQ

BRANFORD, CONN.--(BUSINESS WIRE)--QUANTUM-SI ANNOUNCES SUCCESSFUL SEQUENCING ON INTEGRATED PROTEUS INSTRUMENTS.

Quantum-Si incorporated

QSI

Price

Financial Reports

No items found.

Press Releases

Quantum-Si incorporated

QSI.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

QSI